Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ivy Carroll

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
ACS Chemical Neuroscience|October 5, 2016
Pharmacodynamic Relationships between Duration of Action of JDTic-like Kappa-Opioid Receptor Antagonists and Their Brain and Plasma Pharmacokinetics in RatsS Michael Owens, Gerald T Pollard, James L Howard, et al.
Journal of Medicinal Chemistry|March 3, 2006
N-substituted 4beta-methyl-5-(3-hydroxyphenyl)-7alpha-amidomorphans are potent, selective kappa opioid receptor antagonistsF Ivy Carroll, Matt S Melvin, Michel C Nuckols, et al.
Psychopharmacology|October 25, 2017
Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male ratsMatthew L Lazenka, Megan J Moerke, E Andrew Townsend, et al.
Journal of Medicinal Chemistry|December 4, 2009
Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic)Juan Pablo Cueva, Tingwei Bill Cai, S Wayne Mascarella, et al.
Behavioural Pharmacology|June 26, 2015
Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor systemRachel J Donahue, Samantha M Landino, Sam A Golden, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 5, 2019
The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in ratsJohanna Uhari-Väänänen, Tony Eteläinen, Pia Bäckström, et al.
Advances in Pharmacology (San Diego, Calif.)|February 4, 2014
Bupropion and bupropion analogs as treatments for CNS disordersF Ivy Carroll, Bruce E Blough, S Wayne Mascarella, et al.
ACS Medicinal Chemistry Letters|December 1, 2010
1-Substituted 4-(3-Hydroxyphenyl)piperazines Are Pure Opioid Receptor AntagonistsF Ivy Carroll, Juan Pablo Cueva, James B Thomas, et al.
Journal of Medicinal Chemistry|November 11, 2005
Synthesis and monoamine transporter binding properties of 2,3-diaryltropanesSharadsrikar V Kotturi, Songchun Jiang, An-Chih Chang, et al.
Behavioural Brain Research|December 16, 2018
Blockade of nicotinic acetylcholine receptor enhances the responsiveness to bupropion in the mouse forced swim testDeniz Bagdas, Shakir AlSharari, Monzurul A Roni, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
ACS Chemical Neuroscience|October 5, 2016
Pharmacodynamic Relationships between Duration of Action of JDTic-like Kappa-Opioid Receptor Antagonists and Their Brain and Plasma Pharmacokinetics in RatsS Michael Owens, Gerald T Pollard, James L Howard, et al.
Journal of Medicinal Chemistry|March 3, 2006
N-substituted 4beta-methyl-5-(3-hydroxyphenyl)-7alpha-amidomorphans are potent, selective kappa opioid receptor antagonistsF Ivy Carroll, Matt S Melvin, Michel C Nuckols, et al.
Psychopharmacology|October 25, 2017
Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male ratsMatthew L Lazenka, Megan J Moerke, E Andrew Townsend, et al.
Journal of Medicinal Chemistry|December 4, 2009
Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic)Juan Pablo Cueva, Tingwei Bill Cai, S Wayne Mascarella, et al.
Behavioural Pharmacology|June 26, 2015
Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor systemRachel J Donahue, Samantha M Landino, Sam A Golden, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 5, 2019
The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in ratsJohanna Uhari-Väänänen, Tony Eteläinen, Pia Bäckström, et al.
Advances in Pharmacology (San Diego, Calif.)|February 4, 2014
Bupropion and bupropion analogs as treatments for CNS disordersF Ivy Carroll, Bruce E Blough, S Wayne Mascarella, et al.
ACS Medicinal Chemistry Letters|December 1, 2010
1-Substituted 4-(3-Hydroxyphenyl)piperazines Are Pure Opioid Receptor AntagonistsF Ivy Carroll, Juan Pablo Cueva, James B Thomas, et al.
Journal of Medicinal Chemistry|November 11, 2005
Synthesis and monoamine transporter binding properties of 2,3-diaryltropanesSharadsrikar V Kotturi, Songchun Jiang, An-Chih Chang, et al.
Behavioural Brain Research|December 16, 2018
Blockade of nicotinic acetylcholine receptor enhances the responsiveness to bupropion in the mouse forced swim testDeniz Bagdas, Shakir AlSharari, Monzurul A Roni, et al.
Pageof 19